A new Russian medicine being used on Covid-19 patients has reduced the mortality rate by up to five times, according to its developer, Oleg Rosenberg, of Surfactant-BL. The drug is most commonly used to treat severe lung lesions.
Speaking to Moscow newspaper Izvestia, Rosenberg noted that his creation has not only improved the chances of coronavirus patients staying alive, but it has also kept them off ventilators.
Continue reading https://on.rt.com/apxa